- Specialist Registrar Old Age Psychiatry
I am a psychiatrist in training with a strong interest in new treatments for the major psychiatric disorders. My PhD at the University of Manchester focused on the development of reliable healthy volunteer surrogate models of psychosis to aid Phase 1 clinical trials. After completing the PhD I enrolled in psychiatry training which follows the NIHR integrated academic track - an Academic Clinical Fellowship (Core Training) at the Institute of Psychiatry, Psychology and Neuroscience and South London and Maudsley NHS Trust and I am currently an Academic Clinical Lecturer (Higher Specialty Training) in Psychiatry at the University of Oxford and Oxford Health NHS Foundation Trust. During my time at IoPPN/SLaM I was involved in trials testing the efficacy of novel compounds in psychosis (Sodium Nitroprusside and Cannabidiol).
At the University of Oxford I am working with Professor Simon Lovestone's Translational Neuroscience & Dementia Research Group on the Deep and Frequent Phenotyping study. This is a multi-center study aimed at identifying a combination of biomarkers that predict disease progression in mild and prodromal Alzheimer's disease. This work will inform stratification of patient groups in future proof of concept studies of novel compounds in Alzheimer's disease as well as the choice of biomarker outcome measures.
Koychev I. et al, (2017), Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2, 253 - 262
Koychev I. and Okai D., (2017), Evid Based Ment Health, 20, 15 - 20
Stone J. et al, (2017), Psychol Med
Stone JM. et al, (2016), Psychol Med, 46, 3443 - 3450
Koychev I. et al, (2016), J Clin Psychiatry, 77